Supplemental material, Supplementary_Table_3._Leptin for Gastrointestinal Hormones Manipulation to Counteract Metabolic Syndrome Using Duodenal Targeted Embolization by Raoul Pop, Seong-Ho Kong, Allan Langlois, Francesco Marchegiani, Eran Shlomovitz, András Legnèr, William Bietiger, Michel Pinget, Rémy Beaujeux, Didier Mutter, Jacques Marescaux and Michele Diana in Surgical Innovation</p
Supplemental material, Supplementary_Table_1 for Acute and subacute effects of oropharyngeal sensory...
Supplemental material, Supplementary_Figure_1 for Protective effect of CDDO-imidazolide against inte...
<p>Supplemental material, Supplementary_Table_1 for Establishment of the reference interval for seru...
Supplemental material, Supplementary_Table_4._GIP for Gastrointestinal Hormones Manipulation to Coun...
Supplemental material, Supplementary_Table_5._GLP1 for Gastrointestinal Hormones Manipulation to Cou...
Supplemental material, Supplementary_Table_2._Insulin for Gastrointestinal Hormones Manipulation to ...
Supplemental material, Supplementary_Table_7._RNA_SGLT-1 for Gastrointestinal Hormones Manipulation ...
Supplemental material, Supplementary_Table_8._RNA_GLUT-2 for Gastrointestinal Hormones Manipulation ...
Supplemental material, Supplementary_Table_I_xyz16633105f5516 for Can the Antisecretory Factor Be Co...
<p>Supplemental material, Supplementary_Material for The Therapeutic Potential of Blocking Galectin-...
Supplemental material, Supplementary_Material for Impact of patient and disease characteristics on t...
Supplemental material, Supplementary_Table_1 for Protective effect of CDDO-imidazolide against intes...
Supplemental material, Supplementary_Table_2 for Protective effect of CDDO-imidazolide against intes...
Supplemental material, Supplementary_Material for Drug holiday in patients with polycystic liver dis...
Supplemental material, supplementary_table_1_and_2 for Adjunct Antihyperglycemic Agents in Overweigh...
Supplemental material, Supplementary_Table_1 for Acute and subacute effects of oropharyngeal sensory...
Supplemental material, Supplementary_Figure_1 for Protective effect of CDDO-imidazolide against inte...
<p>Supplemental material, Supplementary_Table_1 for Establishment of the reference interval for seru...
Supplemental material, Supplementary_Table_4._GIP for Gastrointestinal Hormones Manipulation to Coun...
Supplemental material, Supplementary_Table_5._GLP1 for Gastrointestinal Hormones Manipulation to Cou...
Supplemental material, Supplementary_Table_2._Insulin for Gastrointestinal Hormones Manipulation to ...
Supplemental material, Supplementary_Table_7._RNA_SGLT-1 for Gastrointestinal Hormones Manipulation ...
Supplemental material, Supplementary_Table_8._RNA_GLUT-2 for Gastrointestinal Hormones Manipulation ...
Supplemental material, Supplementary_Table_I_xyz16633105f5516 for Can the Antisecretory Factor Be Co...
<p>Supplemental material, Supplementary_Material for The Therapeutic Potential of Blocking Galectin-...
Supplemental material, Supplementary_Material for Impact of patient and disease characteristics on t...
Supplemental material, Supplementary_Table_1 for Protective effect of CDDO-imidazolide against intes...
Supplemental material, Supplementary_Table_2 for Protective effect of CDDO-imidazolide against intes...
Supplemental material, Supplementary_Material for Drug holiday in patients with polycystic liver dis...
Supplemental material, supplementary_table_1_and_2 for Adjunct Antihyperglycemic Agents in Overweigh...
Supplemental material, Supplementary_Table_1 for Acute and subacute effects of oropharyngeal sensory...
Supplemental material, Supplementary_Figure_1 for Protective effect of CDDO-imidazolide against inte...
<p>Supplemental material, Supplementary_Table_1 for Establishment of the reference interval for seru...